<DOC>
	<DOCNO>NCT00793819</DOCNO>
	<brief_summary>Silodosin compare placebo determine safe effective treatment nighttime urination ( nocturia ) men BPH</brief_summary>
	<brief_title>A Study Silodosin 8 mg Daily Treatment Nocturia Men With Benign Prostatic Hyperplasia</brief_title>
	<detailed_description>This multi-center , double-blind , placebo control , parallel , 12 week treatment trial men sign symptom benign prostatic hyperplasia nocturia . The following procedure utilize ; physical exam , electrocardiogram , clinical laboratory test , vital sign , urinary diary , Pittsburgh Quality Sleep Index , Nocturia Quality Life</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Nocturia</mesh_term>
	<mesh_term>Silodosin</mesh_term>
	<criteria>Males good general health least 50 year age , symptom moderate severe BPH nocturia ( &gt; =2 episode per night ) Medical condition would confound efficacy evaluation . Medical condition would unsafe use alphablocker . The use concomitant drug would confound efficacy evaluation . The use concomitant drug would unsafe alphablocker .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>nocturia</keyword>
	<keyword>BPH</keyword>
	<keyword>benign prostate hyperplasia</keyword>
	<keyword>nocturia men benign prostate hyperplasia</keyword>
</DOC>